Malignant

Malignant brain tumors strike deep into the psyche of the receiving and delivering the diagnosis. Malignant gliomas are the common subtype of brain tumors; Brain tumors are highly invasive, aggressive and neurologically destructive tumors which are considered among the deadliest of human cancers. The Median survival ranges from 9 to 12 months and the most aggressive manifestation, glioblastoma, despite maximum treatment efforts.

The technological advances in radiation therapy, neurosurgery, and clinical trials and novel therapeutics. There is progress in the treatment of many common human cancers, such as prostate, breast and lung. The therapies which are used effectively in the treatment of these solid tumors are ineffective in the treatment of glioblastoma.

MALIGANT MEDICATION

• GLIOLAN

Facts of GLIOLAN (5-aminolevulinic acid hydrochloride) Powder 30 mg ?

• Medicine Name: GLIOLAN
• Generic Name: 5-aminolevulinic acid
• Approval Date:
• Company Name: Medac
• Available as (Form & Strength): 30 mg Powder

What are the indications and usage?

Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (WHO grade III and IV).